These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19170988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ, American Red Cross Regional Blood Centers.
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets.
    Kleinman SH, Kamel HT, Harpool DR, Vanderpool SK, Custer B, Wiltbank TB, Nguyen KA, Tomasulo PA.
    Transfusion; 2006 Oct; 46(10):1787-94. PubMed ID: 17002636
    [Abstract] [Full Text] [Related]

  • 7. Canadian experience with detection of bacterial contamination in apheresis platelets.
    Ramírez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M.
    Transfusion; 2007 Mar; 47(3):421-9. PubMed ID: 17319821
    [Abstract] [Full Text] [Related]

  • 8. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H.
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ, Skripchenko A, Myrup A, Awatefe H, Thompson-Montgomery D, Moroff G, Carmichael P, Lin L.
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A, Kurtz J, Moroff G, Wagner SJ.
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
    Heddle NM, Barty RL, Sigouin CS, Boye DM, Nelson EJ, Blajchman MA, Kelton JG.
    Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
    [Abstract] [Full Text] [Related]

  • 13. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [Abstract] [Full Text] [Related]

  • 14. Storage time of blood products and transfusion-related acute lung injury.
    Middelburg RA, Borkent-Raven BA, Janssen MP, van de Watering LM, Wiersum-Osselton JC, Schipperus MR, Beckers EA, Briët E, van der Bom JG.
    Transfusion; 2012 Mar; 52(3):658-67. PubMed ID: 21950582
    [Abstract] [Full Text] [Related]

  • 15. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
    Schrezenmeier H, Walther-Wenke G, Müller TH, Weinauer F, Younis A, Holland-Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J, Deitenbeck R, Förstemann E, Gebauer W, Höchsmann B, Karakassopoulos A, Liebscher UM, Sänger W, Schmidt M, Schunter F, Sireis W, Seifried E.
    Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
    [Abstract] [Full Text] [Related]

  • 16. A critical comparison of platelet preparation methods.
    Vassallo RR, Murphy S.
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [Abstract] [Full Text] [Related]

  • 17. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey.
    Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME, Task Force.
    Transfusion; 2006 Apr; 46(4):636-41. PubMed ID: 16584441
    [Abstract] [Full Text] [Related]

  • 18. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross.
    Benjamin RJ, Kline L, Dy BA, Kennedy J, Pisciotto P, Sapatnekar S, Mercado R, Eder AF.
    Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074
    [Abstract] [Full Text] [Related]

  • 19. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
    Vlaar AP, Wortel K, Binnekade JM, van Oers MH, Beckers E, Gajic O, Schultz MJ, Juffermans NP.
    Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
    [Abstract] [Full Text] [Related]

  • 20. Routine use of Day 6 and Day 7 platelets with rapid testing: two hospitals assess impact 1 year after implementation.
    Harm SK, Szczepiorkowski ZM, Dunbar NM.
    Transfusion; 2018 Apr; 58(4):938-942. PubMed ID: 29332317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.